Drugs for Obstructive Jaundice (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 55)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Lactulose |
Approved |
Phase 4 |
|
4618-18-2 |
11333 |
Synonyms:
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-Dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)OXOLAN-3-YL]OXY-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)TETRAHYDROFURAN-3-YL]OXY-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-DIMETHYLOL-TETRAHYDROFURAN-3-YL]OXY-6-METHYLOL-TETRAHYDROPYRAN-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-[[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)-3-TETRAHYDROFURANYL]OXY]-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-{[(2R,3S,4S,5R)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)OXOLAN-3-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
4-O-b-D-Galactopyranosyl-D-fructofuranose
4-O-b-D-Galactopyranosyl-D-fructose
4-O-beta-delta-Galactopyranosyl-delta-fructofuranose
4-O-beta-delta-Galactopyranosyl-delta-fructose
4-O-beta-D-Galactopyranosyl-D-fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructose
4-O-Î’-D-galactopyranosyl-D-fructofuranose
4-O-Î’-D-galactopyranosyl-D-fructose
ACILAC
Amivalex
Bifiteral
Cephulac
CEPHULAC SYRUP
CHOLAC
Chronulac
CONSTILAC
|
CONSTULOSE
delta-Lactulose
D-Lactulose
Duphalac
DUPHALAC DRY
E966
ENULOSE
EVALOSE
GENERLAC
HEPTALAC
Lactulosa
Lactulose
LACTULOSE JP17
Lactulosum
LAXILOSE
LAXOSE ORANGE
LEMLAX
Normase
OSMOLAX
PORTALAC
REGULOSE
|
|
2 |
|
Nicotinamide |
Approved, Investigational |
Phase 3 |
|
98-92-0 |
936 |
Synonyms:
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
Acid amide
Amid kyseliny nikotinove
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra brand OF niacinamide
Austrovit PP
b 3, Vitamin
b3, Vitamin
Benicot
beta-Pyridinecarboxamide
b-Pyridinecarboxamide
Delonin amide
Dipegyl
Dipigyl
Endobion
Enduramide
Factor PP
FREEDERM
Hansamid
Inovitan PP
Jenapharm brand OF niacinamide
Jenapharm, nicotinsäureamid
m-(Aminocarbonyl)pyridine
Mediatric
Merck brand OF niacinamide
NAM
Nandervit-N
Niacevit
Niacin
Niacinamide
Niacinamide astra brand
Niacinamide jenapharm brand
Niacinamide merck brand
Niacinamide pharmagenix brand
Niamide
NIATIN
Niavit PP
NICAM
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
|
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamide
Nicotinamidum
Nicotinate amide
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsäureamid jenapharm
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Niocinamide
Niozymin
NSC-13128
NSC-27452
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix brand OF niacinamide
PP-Faktor
Propamine a
PYRIDINE-3-CARBOXAMIDE
Pyridine-3-carboxylic acid amide
Savacotyl
Vi-nicotyl
Vi-noctyl
Vitamin b 3
Vitamin b3
Vitamin PP
Witamina PP
Î’-pyridinecarboxamide
|
|
3 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
4 |
|
Niacin |
Approved, Investigational, Nutraceutical |
Phase 3 |
|
59-67-6 |
938 |
Synonyms:
[<sup>3</sup>H]-nicotinic acid
3 Pyridinecarboxylic acid
3-CARBOXYLPYRIDINE
3-CARBOXYPYRIDINE
3-PICOLINIC ACID
3-PYRIDINECARBOXYLATE
3-PYRIDINECARBOXYLIC ACID
3-PYRIDYLCARBOXYLATE
3-PYRIDYLCARBOXYLIC ACID
ACIDE NICOTINIQUE
ACIDO NICOTINICO
ácido nicotínico
ACIDUM NICOTINICUM
AKOTIN
Aluminum salt, niacin
ANTI-PELLAGRA VITAMIN
APELAGRIN
beta-Pyridinecarboxylate
BETA-PYRIDINECARBOXYLIC ACID
b-Pyridinecarboxylate
b-Pyridinecarboxylic acid
DASKIL
EFACIN
ENDURACIN
Hydrochloride, niacin
INDURACIN
LINIC
Lithium nicotinate
m-Pyridinecarboxylate
M-PYRIDINECARBOXYLIC ACID
NIAC
NIACIN
Niacin aluminum salt
Niacin ammonium salt
Niacin calcium salt
Niacin cobalt (2+) salt
Niacin copper (2+) salt
Niacin hydrochloride
Niacin iron (2+) salt
Niacin lithium salt
Niacin lithium salt, hemihydrate
Niacin magnesium salt
Niacin manganese (2+) salt
Niacin potassium salt
Niacin sodium salt
Niacin tartrate
NIACIN TD
Niacin tosylate
Niacin zinc salt
niacin|nicotinate|vitamin B<sub>3</sub>|vitamin PP
Niacina
NIACINE
|
NIACOR
NIASPAN
NIASPAN ER
NIASPAN TITRATION STARTER PACK
NICACID
NICAMIN
NICANGIN
Nico 400
Nico400
Nico-400
NICOBID
NICOCAP
NICODELMINE
NICOLAR
NICONACID
NICOSAN 3
NICO-SPAN
NICOTINATE
Nicotinate, lithium
NICOTINIC ACID
NICOTINIPCA
NICYL
NIKOTINSAEURE
Nikotinsäure
NSC-169454
NYCLIN
P.P. FACTOR
PELLAGRA PREVENTIVE FACTOR
PELLAGRIN
PELONIN
PEVITON
Potassium salt, niacin
PP FACTOR
PYRIDINE-3-CARBOXYLIC ACID
Pyridine-b-carboxylate
Pyridine-b-carboxylic acid
Pyridine-beta-carboxylate
PYRIDINE-BETA-CARBOXYLIC ACID
Pyridine-β-carboxylate
PYRIDINE-Î’-CARBOXYLIC ACID
SIMCOR
SLO-NIACIN
Sodium salt, niacin
Tartrate, niacin
TINIC
Tosylate, niacin
VITAMIN B3
VITAMIN PP
WAMPOCAP
Î’-pyridinecarboxylate
Î’-PYRIDINECARBOXYLIC ACID
|
|
5 |
|
Racemethionine |
Approved, Experimental, Investigational, Nutraceutical |
Phase 3 |
|
59-51-8, 63-68-3, 348-67-4 |
6137 |
Synonyms:
(+-)-Methionine
(+/-)-2-amino-4-(methylmercapto)butyric acid
(2S)-2-Amino-4-(methylsulfanyl)butanoate
(2S)-2-Amino-4-(methylsulfanyl)butanoic acid
(2S)-2-Amino-4-(methylsulphanyl)butanoate
(2S)-2-Amino-4-(methylsulphanyl)butanoic acid
(2S,3R)-2-AMMONIO-3-HYDROXYBUTANOATE
(3R,3'r,6S)-4,5-DIDEHYDRO-5,6-dihydro-b,b-carotene-3,3'-diol
(3R,3'r,6S)-4,5-DIDEHYDRO-5,6-dihydro-BETA,BETA-carotene-3,3'-diol
(3R,3'r,6S)-4,5-DIDEHYDRO-5,6-dihydro-β,β-carotene-3,3'-diol
(L)-Methionine
(S)-(+)-Methionine
(S)-2-Amino-4-(methylthio)butanoate
(S)-2-Amino-4-(methylthio)-butanoate
(S)-2-Amino-4-(methylthio)butanoic acid
(S)-2-Amino-4-(methylthio)-butanoic acid
(S)-2-Amino-4-(methylthio)butyrate
(S)-2-Amino-4-(methylthio)butyric acid
(S)-Methionine
2-amino-4-(methylmercapto)Butyric acid
2-Amino-4-(methylsulfanyl)butanoate
2-Amino-4-(methylsulfanyl)butanoic acid
2-Amino-4-(methylsulphanyl)butanoate
2-Amino-4-(methylsulphanyl)butanoic acid
2-Amino-4-(methylthio)butanoate
2-Amino-4-(methylthio)butanoic acid
2-Amino-4-(methylthio)butyrate
2-amino-4-(methylthio)-Butyric acid
2-Amino-4-(methylthio)butyric acid
2-Amino-4-methylthiobutanoate
2-amino-4-Methylthiobutanoic acid
a-Amino-g-methylmercaptobutyrate
a-Amino-g-methylmercaptobutyric acid
Acimethin
alpha-Amino-alpha-aminobutyric acid
alpha-amino-gamma-(methylthio)Butyric acid
alpha-Amino-gamma-methylmercaptobutyrate
alpha-Amino-gamma-methylmercaptobutyric acid
Bo-xan
Cymethion
DL-2-amino-4-(methylthio)Butanoic acid
DL-2-amino-4-(methylthio)Butyric acid
DL-2-amino-4-(methylthio)-Butyric acid
DL-2-amino-4-Methylthiobutanoic acid
DL-Methionine
DL-Methioninum
e 161b
FEMA 3301
gamma-Methylthio-alpha-aminobutyrate
gamma-Methylthio-alpha-aminobutyric acid
g-Methylthio-a-aminobutyrate
g-Methylthio-a-aminobutyric acid
Hmet
|
H-Met-H
H-Met-OH
L(-)-Amino-alpha-amino-alpha-aminobutyric acid
L(-)-Amino-gamma-methylthiobutyric acid
L-(-)-Methionine
L-(−)-METHIONINE
L-2-Amino-4-(methylthio)butyric acid
L-2-Amino-4methylthiobutyrate
L-2-Amino-4methylthiobutyric acid
L-2-Amino-4-methylthiobutyric acid
L-a-Amino-g-methylmercaptobutyrate
L-a-Amino-g-methylmercaptobutyric acid
L-a-Amino-g-methylthiobutyrate
L-a-Amino-g-methylthiobutyric acid
L-alpha-Amino-gamma-methylmercaptobutyrate
L-alpha-Amino-gamma-methylmercaptobutyric acid
L-alpha-Amino-gamma-methylthiobutyrate
L-alpha-Amino-gamma-methylthiobutyric acid
L-gamma-Methylthio-alpha-aminobutyric acid
Liquimeth
L-Isomer methionine
L-MET
L-Methionin
L-Methionine
L-Methionine Z
L-Methioninum
L-Α-amino-γ-methylmercaptobutyrate
L-Α-amino-γ-methylmercaptobutyric acid
M
Mepron
Met
Methilanin
Methionin
Methionine
Methionine, L isomer
Methionine, L-isomer
Methioninum
Metionina
Neo-methidin
NSC-22946
Padameth
Pedameth
Poly-L-methionine
Polymethionine
Racemethionine
Racemethionine, usan
S-Methionine
S-Methyl-L-homocysteine
Toxin war
Xanthophyll
Α-amino-γ-methylmercaptobutyrate
Α-amino-γ-methylmercaptobutyric acid
|
|
6 |
|
Vitamins |
|
Phase 3 |
|
|
|
7 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
8 |
|
Folate |
|
Phase 3 |
|
|
|
9 |
|
Vitamin B9 |
|
Phase 3 |
|
|
|
10 |
|
Vitamin B3 |
|
Phase 3 |
|
|
|
11 |
|
Trace Elements |
|
Phase 3 |
|
|
|
12 |
|
Nicotinic Acids |
|
Phase 3 |
|
|
|
13 |
|
Antimetabolites |
|
Phase 3 |
|
|
|
14 |
|
Vasodilator Agents |
|
Phase 3 |
|
|
|
15 |
|
Vitamin B Complex |
|
Phase 3 |
|
|
|
16 |
|
Hypolipidemic Agents |
|
Phase 3 |
|
|
|
17 |
|
Lipid Regulating Agents |
|
Phase 3 |
|
|
|
18 |
|
Micronutrients |
|
Phase 3 |
|
|
|
19 |
|
Ursodeoxycholic acid |
Approved, Investigational |
Phase 2 |
|
128-13-2 |
31401 |
Synonyms:
(3a,5b,7b)-3,7-Dihydroxycholan-24-Oate
(3a,5b,7b)-3,7-Dihydroxy-cholan-24-Oate
(3a,5b,7b)-3,7-Dihydroxycholan-24-Oic acid
(3a,5b,7b)-3,7-Dihydroxy-cholan-24-Oic acid
(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-Oate
(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-Oic acid
(3Α,5β,7β)-3,7-dihydroxycholan-24-Oate
(3Α,5β,7β)-3,7-dihydroxycholan-24-Oic acid
(4R)-4-[(1S,2S,5R,7S,9S,10R,11S,14R,15R)-5,9-DIHYDROXY-2,15-DIMETHYLTETRACYCLO[8.7.0.0?,?.0??,??]HEPTADECAN-14-YL]PENTANOIC ACID
3 alpha,7 beta Dihydroxy 5 beta cholan 24 Oic acid
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-Oic acid
3,7-Dihydroxycholan-24-Oic acid
3a,7b-Dihydroxy-5b-cholan-24-Oate
3a,7b-Dihydroxy-5b-cholan-24-Oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-Oate
3alpha,7beta-Dihydroxy-5beta-cholan-24-Oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3Α,7β-dihydroxy-5β-cholan-24-Oate
3Α,7β-dihydroxy-5β-cholan-24-Oic acid
ACG240
Acid, deoxyursocholic
Acid, ursacholic
Acid, ursodeoxycholic
Acide ursodesoxycholique
Acido ursodeossicolico
Acido ursodeoxicolico
Acidum ursodeoxycholicum
Actigall
Antigall
Antigen brand OF ursodeoxycholic acid
Aventis brand OF ursodeoxycholic acid
Axcan brand OF ursodeoxycholic acid
Cholit-ursan
Cholofalk
CHOLURSO
CP Brand OF ursodeoxycholic acid
Delursan
Deoxyursocholic acid
|
Destolit
Estedi brand OF ursodeoxycholic acid
Falk brand OF ursodeoxycholic acid
Farmasa brand OF ursodeoxycholic acid
Galen brand OF ursodeoxycholic acid
Heumann brand OF ursodeoxycholic acid
Niddapharm brand OF ursodeoxycholic acid
Norgine brand OF ursodeoxycholic acid
NSC-683769
Orphan brand OF ursodeoxycholic acid
Provalis brand OF ursodeoxycholic acid
Sanofi synthelabo brand OF ursodeoxycholic acid
Sodium ursodeoxycholate
Tramedico brand OF ursodeoxycholic acid
UDCA
Urdox
Urosdesoxycholate
Urosdesoxycholic acid
Ursacholic acid
Urso
URSO 250
URSO FORTE
Urso heumann
Ursobilane
Ursochol
Ursodeoxycholate
Ursodeoxycholate, sodium
URSODEOXYCHOLIC ACID
Ursodeoxycholicacid
URSODESOXYCHOLIC ACID
Ursodexycholate
Ursodexycholic acid
Ursodiol
Ursofalk
Ursogal
Ursolite
Ursolvan
Vita brand OF ursodeoxycholic acid
Zambon brand OF ursodeoxycholic acid
|
|
20 |
|
Neostigmine |
Approved, Vet_approved |
Phase 1, Phase 2 |
|
59-99-4 |
4456 5824 |
Synonyms:
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamic acid
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYL-AMMONIUM
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYLAZANIUM
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYL-AZANIUM
[3-[DIMETHYLAMINO(OXO)METHOXY]PHENYL]-TRIMETHYLAMMONIUM
3-Trimethylammoniumphenyl N,N-dimethylcarbamate
3-Trimethylammoniumphenyl N,N-dimethylcarbamic acid
BLOXIVERZ
Bromide, neostigmine
Eustigmin
Eustigmine
Methylsulfate, neostigmine
m-Trimethylammoniumphenyldimethylcarbamate
m-Trimethylammoniumphenyldimethylcarbamic acid
Neostigmina
NEOSTIGMINE
|
Neostigmine bromide
NEOSTIGMINE METHYL SULFATE
Neostigmine methylsulfate
NEOSTIGMINE METILSULFATE
NSC-93753
Polstigmine
Proserine
Prostigmin
PROSTIGMIN (TN)
Prostigmin®
Prostigmine
Prozerin
ROBINUL-NEOSTIG
Synstigmin
Syntostigmine
Vagostigmine
|
|
21 |
|
Gastrointestinal Agents |
|
Phase 2 |
|
|
|
22 |
|
Neurotransmitter Agents |
|
Phase 1, Phase 2 |
|
|
|
23 |
|
Anti-Inflammatory Agents |
|
Phase 1, Phase 2 |
|
|
|
24 |
|
Cholinesterase Inhibitors |
|
Phase 1, Phase 2 |
|
|
|
25 |
|
Cholinergic Agents |
|
Phase 1, Phase 2 |
|
|
|
26 |
|
Liver Extracts |
|
Phase 1, Phase 2 |
|
|
|
27 |
|
Omega 3 Fatty Acid |
|
Phase 1, Phase 2 |
|
|
|
28 |
|
Parenteral Nutrition Solutions |
|
Phase 1, Phase 2 |
|
|
|
29 |
|
bilirubin |
|
Phase 1, Phase 2 |
|
635-65-4 |
5280352 |
Synonyms:
(4Z,15Z)-Bilirubin ixa
(Z,Z)-Bilirubin ixa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionic acid
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid
2,7,13,17-Tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoate
2,7,13,17-Tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
|
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
8,12-Bis(2-carboxyethyl)-2,7,13,17-tetramethyl-3,18-divinylbiladiene-ac-1,19(21H,24H)-dione
BILIRUBIN
Bilirubin IX alpha
Bilirubin ixalpha
Bilirubin IX-alpha
Bilirubin(Z,Z)
Bilirubin-ixalpha
Cholerythrin
Hematoidin
NSC-26685
|
|
30 |
|
SMOFlipid |
|
Phase 1, Phase 2 |
|
|
|
31 |
|
Fat Emulsions, Intravenous |
|
Phase 1, Phase 2 |
|
|
|
32 |
|
Soy Bean |
|
Phase 1, Phase 2 |
|
|
|
33 |
|
Olive |
|
Phase 1, Phase 2 |
|
|
|
34 |
|
Norepinephrine |
Approved |
Phase 1 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(−)-noradrenaline
(-)-Noradrenaline
(−)-norepinephrine
(-)-Norepinephrine
(-)-norepinephrine|Levarterenol®|noradrenaline
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-norepinephrine
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]PYROCATECHOL
Adrenor
Aktamin
Arterenol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
|
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-Arterenol
Levarterenol
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
L-noradrenaline
L-Norepinephrine
Noradrenalin
Noradrenaline
Nor-adrenaline
Norartrinal
Norepinefrina
Norepinephrine
Norépinéphrine
Norepinephrinum
Norepirenamine
Nor-epirenan
R-NOREPINEPHRINE
Sympathin E
|
|
35 |
|
Methylene blue |
Approved, Investigational |
Phase 1 |
|
61-73-4 |
6099 |
Synonyms:
3,7-BIS(DIMETHYLAMINO)PHENAZATHIONIUM CHLORIDE
aniline violet
Azul de metileno
BASIC BLUE 9
C.I. 52015
C.I. BASIC BLUE 9
Chlorure de méthylthioninium
CI 52015
CI-52015
Cloruro de metiltioninio
EHRLICH'S REAGENT III
LOWACRYL BLUE 9
METHYLENE BLUE
METHYLENE BLUE ANHYDROUS
METHYLENE BLUE TRIHYDRATE
|
METHYLENIUM CERULEUM
METHYLTHIONINE CHLORIDE
METHYLTHIONINE HCL
Methylthioninii chloridum
METHYLTHIONINIUM CHLORIDE
methylthioninium chloride Proveblue
NSC-215213
NSC-617593
PROVAYBLUE
SOLVENT BLUE 8
SWISS BLUE
tetrametylthionine chloride
TRX0014
UROLENE BLUE
VIB100
|
|
36 |
|
Prednisone |
Approved, Vet_approved |
|
|
53-03-2 |
5865 |
Synonyms:
1,2-Dehydrocortisone
1,4-Pregnadiene-17a,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17α,21-diol-3,11,20-trione
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
Acis brand OF prednisone
Acsis, prednison
Adasone
Ancortone
Apo-prednisone
Apotex brand OF prednisone
Aventis brand OF prednisone
Betapar
Bicortone
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
Cutason
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta-cortelan
Deltacortene
delta-Cortisone
Deltacortisone
Deltacortone
Delta-cortone
DELTA-DOME
Deltasone
Deltison
Deltisona
Deltisone
Deltra
Diadreson
Di-Adreson
Diba brand OF prednisone
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fawns and mcallan brand OF prednisone
FERNISONE
Ferring brand OF prednisone
Fiasone
GALENpharma brand OF prednisone
Halsey drug brand OF prednisone
Hexal brand OF prednisone
Hoechst brand OF prednisone
Hostacortin
ICN brand OF prednisone
Incocortyl
In-Sone
Juvason
Kortancyl
Lichtenstein brand OF prednisone
|
Liquid pred
Lisacort
LODOTRA
Lodotra®|Sterapred®
Me-Korti
Merck brand OF prednisone
Merz brand OF prednisone
Metacortandracin
Meticorten
Mibe brand OF prednisone
Nisona
Nizon
Novoprednisone
NSC-10023
Nurison
Orasone
Origen Prednisone
Panafcort
Panasol
PARACORT
Parmenison
Pehacort
Pharmacia brand OF prednisone
PRD
Precort
Predeltin
PREDN
Predni tablinen
PREDNICEN-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Predniment
Prednison
Prednison acsis
Prednison galen
Prednison hexal
Prednisona
Prednisona [INN-Spanish]
Prednisone
PREDNISONE INTENSOL
PREDNISONE TABLETS
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Pronison
Pronisone
RAYOS
Rectodelt
Retrocortine
Schering-plough brand OF prednisone
Seatrace brand OF prednisone
SERVISONE
Solvay brand OF prednisone
Sone
Sterapred
Supercortil
Trommsdorff brand OF prednisone
Ultracorten
Ultracortene
Winpred
Wojtab
Zenadrid
|
|
37 |
|
Pancrelipase |
Approved, Investigational |
|
|
53608-75-6 |
8519 |
Synonyms:
1,4-ALPHA-D- GLUCAN GLUCANOHYDROLASE
ACCELERASE
COTAZYM
COTAZYM-S
CREON
Endothall
Endothall dipotassium salt
Endothall disodium salt
Endothall disodium salt, (endo,endo)-isomer
Endothall, diammonium salt
ENTOLASE
ILOZYME
KU-ZYME HP
LIPANCREATIN
lipase
|
PA
Pancrealipase
PANCREASE
PANCREATIC ALPHA-AMYLASE PRECURSOR
Pancreatic extract pancrelipase
Pancreatic protease
Pancreatin
Pancreatinum
PANCRELIPASE
Pancrelipase (amylase
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
protease)
VIOKASE
ZYMASE
|
|
38 |
|
Trioxsalen |
Approved |
|
|
3902-71-4 |
5585 |
Synonyms:
2',4,8-Trimethylpsoralen
2,5,9-Trimethyl-7H-furo(3,2-g)benzopyran-7-one
4,5',8-Trimethylpsoralen
4,8,5'-Trimethylpsoralen
6-Hydroxy-b,2,7-trimethyl-5-benzofuranacrylate, delta-lactone
6-Hydroxy-b,2,7-trimethyl-5-benzofuranacrylate, δ-lactone
6-Hydroxy-b,2,7-trimethyl-5-benzofuranacrylic acid, delta-lactone
6-Hydroxy-b,2,7-trimethyl-5-benzofuranacrylic acid, δ-lactone
6-Hydroxy-beta,2,7-trimethyl-5-benzofuranacrylate, delta-lactone
6-Hydroxy-beta,2,7-trimethyl-5-benzofuranacrylic acid, delta-lactone
6-Hydroxy-β,2,7-trimethyl-5-benzofuranacrylate, δ-lactone
|
6-Hydroxy-β,2,7-trimethyl-5-benzofuranacrylic acid, δ-lactone
ICN brand OF trioxsalen
Trimethylpsoralen
Trioxisaleno
Trioxisalenum
TRIOXSALEN
Trioxysalen
Trioxysalene
Trioxysalenum
Trisoralen
|
|
39 |
|
Ceftriaxone |
Approved |
|
|
73384-59-5 |
5479530 |
Synonyms:
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Anhydrous ceftriaxone sodium
Benaxona
Biotrakson
Boehringer mannheim brand OF ceftriaxone sodium
C18H18N8O7S3
Cefatriaxone
Cefaxona
Ceftrex
Ceftriaxon
Ceftriaxon curamed
Ceftriaxon hexal
Ceftriaxona
Ceftriaxona [INN-Spanish]
Ceftriaxona andreu
Ceftriaxona LDP torlan
CEFTRIAXONE
Ceftriaxone irex
Ceftriaxone sodium
Ceftriaxone sodium, anhydrous
Ceftriaxone, disodium salt
Ceftriaxone, disodium salt, hemiheptahydrate
Ceftriaxonum
|
Ceftriaxonum [INN-Latin]
Ceftriazone
Columbia brand OF ceftriaxone
CTRX
Curamed brand OF ceftriaxone sodium
FIDATO
Fustery brand OF ceftriaxone sodium
Galen brand OF ceftriaxone sodium
Hexal brand OF ceftriaxone sodium
Hoffman la roche brand OF ceftriaxone sodium
Hoffman-la roche brand OF ceftriaxone sodium
Inibsa brand OF ceftriaxone sodium
Irex brand OF ceftriaxone
Lendacin
Longacef
Longaceph
Pisa brand OF ceftriaxone sodium
Rocefalin
Rocefin
Rocephin
Rocephine
Roche brand OF ceftriaxone sodium
Sodium, ceftriaxone
Syntex brand OF ceftriaxone sodium
Tacex
Terbac
|
|
40 |
|
Dihematoporphyrin ether |
Investigational |
|
|
97067-70-4 |
|
Synonyms:
bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl ether
DHP ether
|
|
|
41 |
|
Diethyl ether |
Experimental |
|
|
60-29-7 |
3283 |
Synonyms:
1,1'-Oxybisethane
3-Oxapentane
Aether
Aether pro narcosi
Anesthetic ether
Diethyl ether
Diethyl oxide
Diethylaether
Ether
|
Ether, diethyl
Ether, ethyl
Ethoxyethane
Ethyl ether
Ethyl oxide
NSC-100036
Pronarcol
R-610
SOLVENT ETHER
|
|
42 |
|
Immunoglobulins, Intravenous |
|
|
|
|
|
43 |
|
Immunoglobulins |
|
|
|
|
|
44 |
|
Immunoglobulin G |
|
|
|
|
|
45 |
|
Antibodies |
|
|
|
|
|
46 |
|
Pancreatin |
|
|
|
|
|
47 |
|
Photosensitizing Agents |
|
|
|
|
|
48 |
|
Hematoporphyrins |
|
|
|
|
|
49 |
|
Hematoporphyrin Derivative |
|
|
|
|
|
50 |
|
Dermatologic Agents |
|
|
|
|
|
Interventional clinical trials:
(show all 45)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Phase 4 Study :Human Kidney Histopathology in Acute Obstructive Jaundice: a Prospective Study |
Completed |
NCT01090193 |
Phase 4 |
|
2 |
Re-intervention for Occluded Biliary Metal Stent in Malignant Distal Bile Duct Obstruction: a Prospective Randomized Multi-center Trial Comparing Covered and Uncovered Metal Stent |
Completed |
NCT01315522 |
Phase 4 |
|
3 |
Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice: A Phase III, Randomized, Controlled, Single Center Study. |
Unknown status |
NCT01744938 |
Phase 3 |
|
4 |
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Trial of Efficacy and Safety of Remaxol®, a Solution for Intravenous Infusions Produced by STPF "POLYSAN" (Russia), in Patients With Mechanical Jaundice of Non-Malignant Origin |
Completed |
NCT03418935 |
Phase 3 |
Remaxol (succinate + methionine + inosine + nicotinamide);Ringer's Solution |
5 |
A Multicenter, Double-blind, Placebo-controlled, Randomized Trial of the Efficacy and Safety of Remaxol®, a Solution for Infusions Produced by STPF POLYSAN (Russia), in Patients With Malignant Mechanical Jaundice |
Completed |
NCT03416062 |
Phase 3 |
Remaxol®;Ringer's Solution |
6 |
Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction |
Withdrawn |
NCT01622803 |
Phase 3 |
|
7 |
The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice After Endoscopic or Surgical Treatment |
Unknown status |
NCT01688375 |
Phase 2 |
Ursodeoxycholic Acid |
8 |
A Double Blind, Randomized Controlled Prospective Trial of Endo-biliary Radio-frequency Ablation for Maintenance of Metal Stent Patency in Patients With Malignant Obstructive Jaundice |
Unknown status |
NCT01275768 |
Phase 1, Phase 2 |
|
9 |
The Prevention and Treatment of SIRS in Patients With Cholestatic Jaundice After Operation. |
Unknown status |
NCT02279147 |
Phase 1, Phase 2 |
neostigmine methylsulfate,raceanisodamine hydrochloride |
10 |
Investigation of the Effect of Intraductal Radiofrequency Ablation in Inoperable Biliopancreatic Tumors Complicated With Obstructive Jaundice |
Completed |
NCT02468076 |
Phase 2 |
|
11 |
Self Expanding Metal Stents (SEMS) or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors. |
Completed |
NCT02166840 |
Phase 2 |
|
12 |
Compassionate Use of an Intravenous Fat Emulsion Comprised of Soy Oil, Medium Chain Triglycerides, Olive Oil, and Fish Oil for Neonates With Parenteral Nutrition Induced Liver Injury |
Terminated |
NCT02721277 |
Phase 1, Phase 2 |
SMOFlipid |
13 |
Effect of Methylene Blue on Perioperative Organ Function in Patients With Obstructive Jaundice |
Unknown status |
NCT04109859 |
Phase 1 |
Saline;Methylene Blue |
14 |
Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids |
Unknown status |
NCT02797665 |
|
corticosteroids |
15 |
Process Optimization of Preoperative Biliary Drainage in Patients With Malignant Obstructive Jaundice of Extrahepatic Bile Duct: A Multi-center, Prospective, Open-labeled, Real World Study Based on Electronic Data Capture System |
Unknown status |
NCT03527875 |
|
|
16 |
The Preventive Effects of Pre-treatment With Methylene Blue for Vascular Paralysis of the Patients With Obstructive Jaundice During Operation |
Unknown status |
NCT03406676 |
|
Methylene Blue |
17 |
Quorum Sensing Signal Molecules (QSSMs) and Immune Dysfunction in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) for Obstructive Jaundice |
Unknown status |
NCT01367821 |
|
|
18 |
A Multisite, Open-label, Prospective Cohort Study Investigating Huaier Granule Combined With Biliary Drainage for Treatment of Malignant Obstructive Jaundice(MOJ) |
Unknown status |
NCT03491254 |
|
|
19 |
The Role of Cholangioscopy and Biliary Radio Frequency Ablation in the Management of Occluded Biliary Self-expanding Metal Stent. |
Unknown status |
NCT03133026 |
|
|
20 |
A Randomized Trial Comparing Covered Metal and Plastic Stents for Preoperative Biliary Decompression in Pancreatic Cancer |
Unknown status |
NCT01191814 |
|
|
21 |
Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders |
Unknown status |
NCT01438385 |
|
|
22 |
Endoscopic Access Loop With Bilio-enteric Anastomosis: A Prospective Randomized Comparison Between Gastric and Subcutaneous Accesses |
Unknown status |
NCT03252379 |
|
|
23 |
Safety and Efficacy of n-3 Fatty Acid-based Parenteral Nutrition in Patients With Obstructive Jaundice: A Propensity-matched Study |
Completed |
NCT03376945 |
|
trail cohort;control cohort |
24 |
Prospective Study on the Comparison Between the Clinicopathological Outcomes According to the Methods of Preoperative Biliary Drainage in Periampullary Cancers Causing Obstructive Jaundice |
Completed |
NCT01134276 |
|
|
25 |
Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio-pancreatic Malignancies: a Multicenter Prospective Study (ECCO Trial) |
Completed |
NCT05155475 |
|
|
26 |
Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio-Pancreatic Malignancies: A Multicenter Prospective Study |
Completed |
NCT03494023 |
|
|
27 |
Endoscopic Versus Percutaneous Biliary Drainage For Hilar Block Due to Carcinoma Gall Bladder: A Randomized Prospective Trial and Quality Of Life Assessment |
Completed |
NCT00409864 |
|
|
28 |
The Status of Advanced Endoscopy in the Era of COVID-19: a Multicenter Study |
Completed |
NCT04385147 |
|
|
29 |
Multicenter Randomized Trial Comparing Covered Metal and Plastic Stents for Preoperative Biliary Decompression in Pancreatic Cancer |
Completed |
NCT01675908 |
|
|
30 |
Endoscopic Versus Percutaneous Biliary Drainage for Resectable Pancreatic Head Cancer With Hyperbilirubinemia and Impact on Pancreaticoduodenectomy: A Prospective Cohort Study |
Completed |
NCT04823832 |
|
|
31 |
Endoscopic Ultrasound-guided Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP: a Single Italian Center Experience |
Completed |
NCT03510754 |
|
|
32 |
A Double-blind, Randomized, Controlled Trial of Air Insufflation Versus Carbon Dioxide Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP). |
Completed |
NCT01321203 |
|
|
33 |
Observational Study for Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma |
Completed |
NCT01506115 |
|
Photofrin |
34 |
Multicenter RCT Comparing Two Brushes of Different Diameters for Biliary Stenosis: RX Cytology Brush, BOSTON vs. Infinity® Brush, US Endoscopy. BIB Study (BIliary Brushing) |
Completed |
NCT04251013 |
|
|
35 |
Full Data BDI Digestif RSCM |
Completed |
NCT04582240 |
|
|
36 |
Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography: Precut Versus Conventional Cannulation. A Prospective Randomized Study |
Completed |
NCT02477228 |
|
|
37 |
Multicenter Prospective Randomized Controlled Trial of the Nitinol ZILVER Expandable Endoprosthesis in the Palliation of Extrahepatic Malignant Biliary Obstruction |
Completed |
NCT00196105 |
|
|
38 |
The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice |
Recruiting |
NCT04620577 |
|
|
39 |
Role of Ultrasonography as a Single Tool for Guidance of Percutaneous Transhepatic Biliary Drainage in Obstructive Jaundice |
Recruiting |
NCT05246176 |
|
|
40 |
Prospective Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis |
Recruiting |
NCT03977779 |
|
|
41 |
Influence of Percutaneous Biliary Drainage on the Change of Enzyme Activity of Matrix Metalloproteinases in the Serum of Patients With Malignant Obstructive Hyperbilirubinemia |
Recruiting |
NCT04801914 |
|
|
42 |
Role of Biodegradable Polydioxanone Biliary Stents for the Percutaneous Treatment of Benign Biliary Strictures. |
Active, not recruiting |
NCT05556668 |
|
|
43 |
Comparison of Efficacy and Safety of Endoscopic Biliary Drainage and Percutaneous Transhepatic Biliary Drainage for the Management of Perihilar Malignant Biliary Obstruction: a Monocentric Retrospective Study |
Active, not recruiting |
NCT05078801 |
|
|
44 |
preGallstep: One-step Laparoscopic Cholecystectomy, Common Bile Duct Exploration and Stone Extraction Versus Two-step Endoscopic Retrograde Cholangiography and Stone Extraction Plus Laparoscopic Cholecystectomy for Common Bile Duct Stones |
Not yet recruiting |
NCT04801238 |
|
|
45 |
Preoperative Endoscopic Biliary Drainage With Self Expanding Metal Stents (SEMS) vs. Direct Surgical Resection for Patients With Severe Obstructive Jaundice |
Terminated |
NCT03820544 |
|
|
|